The role of erbB2 signal transduction pathways in human breast cancer
Data up to Jan 2025
Total Citations Per Year
Abstract
References (47)
Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene
1987 • 11,429 citations
Cancer: Principles and Practice of Oncology.
1991 • 8,402 citations
Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer
1989 • 6,734 citations
Tyrosine Kinase Receptor with Extensive Homology to EGF Receptor Shares Chromosomal Location with neu Oncogene
1985 • 1,804 citations
Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor
1986 • 1,226 citations
[42] Detection and quantification of phosphotyrosine in proteins
1983 • 1,184 citations
Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene
1988 • 1,160 citations
The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen
1984 • 1,153 citations
The neu oncogene encodes an epidermal growth factor receptor-related protein
1986 • 1,131 citations
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
1987 • 1,015 citations
The principles and practice of oncology
2001 • 966 citations
Identification of Heregulin, a Specific Activator of p185 erbB2
1992 • 963 citations
Neu-Protein Overexpression in Breast Cancer
1988 • 860 citations
Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts
1981 • 795 citations
p185HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor
1989 • 672 citations
Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells.
1987 • 627 citations
A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma.
1985 • 607 citations
Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: prognostic significance of erbB-2 protein overexpression in primary breast cancer.
1990 • 602 citations
Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.
1989 • 592 citations
Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
1992 • 579 citations
Direct activation of the serine/threonine kinase activity of raf-1 through tyrosine phosphorylation by the PDGF β-receptor
1989 • 513 citations
A secreted glycoprotein induced by estrogen in human breast cancer cell lines
1980 • 481 citations
p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor.
1989 • 479 citations
PDGF induction of tyrosine phosphorylation of GTPase activating protein
1989 • 478 citations
Down-modulation of an oncogene protein product and reversion of the transformed phenotype by monoclonal antibodies
1985 • 408 citations
AMPLIFICATION OF c-erbB-2 ONCOGENE IN HUMAN ADENOCARCINOMAS IN VIVO
1986 • 400 citations
Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene
1989 • 395 citations
Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line.
1986 • 329 citations
Antiphosphotyrosine Recovery of Phospholipase C Activity After EGF Treatment of A-431 Cells
1988 • 324 citations
Direct Interaction of a Ligand for the erb B2 Oncogene Product with the EGF Receptor and p185 erb B2
1990 • 279 citations
A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines.
1991 • 229 citations
Cell growth and differentiation
2005 • 226 citations
Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine.
1984 • 209 citations
Characterization and use of monoclonal antibodies for isolation of phosphotyrosyl proteins from retrovirus-transformed cells and growth factor-stimulated cells.
1983 • 200 citations
A v-erbB-related protooncogene, c-erb-B-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma
1985 • 195 citations
ERBB2 amplification in breast cancer with a high rate of proliferation.
1991 • 191 citations
Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer.
1991 • 187 citations
Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene.
1988 • 186 citations
Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
1990 • 162 citations
Human microvascular endothelial cells express receptors for platelet-derived growth factor.
1991 • 154 citations
Epidermal growth factor receptor (EGFr) as a marker for poor prognosis in node-negative breast cancer patients: Neu and tamoxifen failure
1990 • 147 citations
Characterization of a growth factor that binds exclusively to the erbB-2 receptor and induces cellular responses.
1992 • 117 citations
A ligand for the erbB-2 oncogene product (gp30) induces differentiation of human breast cancer cells.
1992 • 90 citations
Characterization and Use of Monoclonal Antibodies for Isolation of Phosphotyrosyl Proteins from Retrovirus-Transformed Cells and Growth Factor-Stimulated Cells
1983 • 66 citations
Lactate dehydrogenase in estrogen-responsive human breast cancer cells.
1978 • 64 citations
Purification and characterization of the neu/erb B2 ligand-growth factor from bovine kidney.
1992 • 39 citations
Characterization and cloning of the gp30 ligand for the erbB-2 receptor, from human breast cancer cells
1993 • 1 citations